Form D — Qualigen Therapeutics, Inc.
0001641172-25-023575 · filed Aug 13, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $4,500,000
- Reported amount sold
- $4,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Qualigen Therapeutics, Inc.
- CIK
- 1460702
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5857 OWENS AVENUE
CARLSBAD, California 92008 - Phone
- (760) 452-8111
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Kevin Richardson II · DirectorCarlsbad, California Find on LinkedIn ↗
-
Campbell Becher · Executive OfficerCarlsbad, California Find on LinkedIn ↗
-
Braeden Lichti · DirectorCarlsbad, California Find on LinkedIn ↗
-
Robert B. Lim · DirectorCarlsbad, California Find on LinkedIn ↗
-
Cody Price · DirectorCarlsbad, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗